Analyze the Relationship Between the Expression of Specific Genes and the Prognosis in Pediatric Gliomas

Ongoing
Data
HGG
LGG
Asset 11.png

CBTN Data

About this

Project

The protein encoded by SETD1A (SET Domain Containing 1A, Histone Lysine Methyltransferase) is a component of a histone methyltransferase (HMT) complex that produces mono-, di-, and trimethylated histone H3 at Lys4. Literatures have found that SETD1A is required for survival of acute myeloid leukemia (AML) cells. H3K4me3 levels positively correlate with WHO grade malignancy in pediatric EPNs and reduction of H3K4me3 by silencing SETD1A increases cell response to chemotherapy. However, we found that there is no significant differences of SETD1A in different glioma types or grades by analyzing data in TCGA and CGGA databases. Our follow-on plan is to compare the expression of SETD1A in pediatric gliomas, and to find upstream or downstream candidate genes. At the same time, immunohistochemistry and immunoblotting will be used in human glioma tissue and animal models to verify key genes and discover possible targeted genes.

Ask The

Scientists

Ask the scientists

Explore the data in these informatics portals

kidsfirstdrc_logo.png